| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $635M | $690M | $655M | -8.0% | -2.9% |
| Op. Income | $110M | $131M | $133M | -15.8% | -17.1% |
| Gross Margin | 30.0% | 30.4% | 31.7% | -0.3pp | -1.7pp |
| Net Margin | 12.8% | 14.5% | 16.9% | -1.7pp | -4.1pp |
| EPS (Diluted) | $8.62 | $10.67 | $11.56 | -19.2% | -25.4% |
| Free Cash Flow | $117M | $122M | $171M | -4.0% | -31.3% |
| Item | Amount |
|---|---|
| REVENUE | $635M |
| Cost of Revenue | $445M |
| GROSS PROFIT | $191M |
| R&D Expenses | $32M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $49M |
| Other Expenses | $0 |
| Operating Expenses | $81M |
| Cost & Expenses | $525M |
| OPERATING INCOME | $110M |
| Interest Income | $0 |
| Interest Expense | $10M |
| Other Income/Expenses | $3M |
| INCOME BEFORE TAX | $113M |
| Income Tax Expense | $32M |
| Net Income from Continuing Ops | $81M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $81M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $81M |
| D&A | $32M |
| EBIT | $110M |
| EBITDA | $142M |
| EPS | $9 |
| EPS Diluted | $9 |
| Item | Amount |
|---|---|
| REVENUE | $635M |
| Cost of Revenue | $445M |
| GROSS PROFIT | $191M |
| R&D Expenses | $32M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $49M |
| Other Expenses | $0 |
| Operating Expenses | $81M |
| Cost & Expenses | $525M |
| OPERATING INCOME | $110M |
| Interest Income | $0 |
| Interest Expense | $10M |
| Other Income/Expenses | $3M |
| INCOME BEFORE TAX | $113M |
| Income Tax Expense | $32M |
| Net Income from Continuing Ops | $81M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $81M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $81M |
| D&A | $32M |
| EBIT | $110M |
| EBITDA | $142M |
| EPS | $9 |
| EPS Diluted | $9 |
| Item | Amount |
|---|---|
| Net Income | $81M |
| Depreciation & Amortization | $32M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $22M |
| Other Non-Cash Items | $0 |
| Change in Working Capital | $10M |
| OPERATING CASH FLOW | $145M |
| Capital Expenditure | -$28M |
| Acquisitions (Net) | -$213M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$241M |
| Net Debt Issuance | $100M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$28M |
| Other Financing Activities | -$838.0K |
| NET CASH FROM FINANCING | $71M |
| FREE CASH FLOW | $117M |
| Net Change in Cash | -$25M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $78M |
| Short-Term Investments | $0 |
| Net Receivables | $422M |
| Inventory | $502M |
| Other Current Assets | $58M |
| TOTAL CURRENT ASSETS | $1.1B |
| PP&E (Net) | $854M |
| Goodwill | $941M |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $638M |
| TOTAL NON-CURRENT ASSETS | $2.4B |
| TOTAL ASSETS | $3.5B |
| Account Payables | $238M |
| Short-Term Debt | $16M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $165M |
| TOTAL CURRENT LIABILITIES | $419M |
| Long-Term Debt | $945M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $350M |
| TOTAL NON-CURRENT LIABILITIES | $1.3B |
| TOTAL LIABILITIES | $1.7B |
| Common Stock | $2M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $1.7B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $107M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.8B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.8B |
| TOTAL LIABILITIES & EQUITY | $3.5B |
| Total Debt | $962M |
| Net Debt | $884M |
